Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer
Rhea-AI Summary
Amesite (Nasdaq: AMST) announced a new enterprise customer for its AI-native NurseMagic™ platform, covering an approximately 2,700-patient census, its largest deployment to date. The rollout aims to cut administrative work that can reach 16 hours per caregiver per week and integrates EMR and EVV workflows.
Amesite reports NurseMagic™ has supported an approximately 18% reduction in operating spend over six quarters while its digital funnel delivers about 4,200 web visits per day and a growing pipeline of enterprise opportunities in the non-acute/post-acute care market.
AI-generated analysis. Not financial advice.
Positive
- Largest NurseMagic™ deployment with approximately 2,700-patient census enterprise customer
- Platform targets reduction of up to 16 administrative hours per caregiver per week
- Approximately 18% reduction in operating spend over the last 6 quarters
- Around 4,200 web visits per day driving inbound provider interest
- Advanced discussions with additional organizations representing several thousand more patients
- Enterprise-scale deployment demonstrates AI-first, configurable model and unit economics focus
Negative
- None.
News Market Reaction – AMST
On the day this news was published, AMST gained 120.07%, reflecting a significant positive market reaction. Argus tracked a peak move of +277.6% during that session. Our momentum scanner triggered 48 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $6M to the company's valuation, bringing the market cap to $10.13M at that time. Trading volume was exceptionally heavy at 8.1x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Three software peers in momentum scan are all down (median -2.9%), while AMST slipped -0.87%, suggesting the stock moved within a broader weak sector tape pre-announcement.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 28 | Equity offerings closed | Negative | +8.2% | Closed concurrent offerings with potential proceeds up to $7.8M including warrants. |
| Apr 28 | Insider-led placement | Negative | -6.7% | Insider-led private placement at $1.435 per share to raise about $600,000. |
| Apr 27 | Registered direct & PIPE | Negative | -33.5% | Announced up to $6M in concurrent registered direct and private placements. |
| Apr 27 | S-1 withdrawal, update | Negative | -33.5% | Withdrew S-1 offering and highlighted NurseMagic™ market and usage metrics. |
| Mar 26 | EVV integration deal | Positive | +6.4% | Signed HIPAA-compliant EVV trading-partner agreement and reported strong revenue growth. |
Financing and capital-structure headlines have often led to sharp downside, while product and integration news have seen more supportive reactions.
Over the last few months, Amesite has balanced capital raising with progress on its AI-native NurseMagic™ platform. Multiple April financings and related SEC filings brought in up to $7.8M potential proceeds and helped restore Nasdaq equity compliance, but shares fell sharply on several of those announcements. By contrast, the Mar 26 trading-partner agreement enabling HIPAA-compliant EVV connectivity and highlighting strong revenue growth saw a positive reaction. Today’s 2,700-census enterprise win continues the trajectory of scaling NurseMagic™ in home-care workflows.
Market Pulse Summary
The stock surged +120.1% in the session following this news. A strong positive reaction aligns with the company’s pivot toward scalable, AI-native healthcare solutions. This announcement added a 2,700-patient enterprise deployment, highlighted an approximately 18% operating-spend reduction over six quarters, and pointed to 4,200 daily web visits with over 70% self-scheduled demos. Historically, product and integration wins such as the Mar 26 EVV agreement saw supportive moves, but prior dilutive financings created volatility, which could still influence future trading.
Key Terms
emr medical
electronic visit verification (evv) regulatory
non-acute care medical
post-acute medical
AI-generated analysis. Not financial advice.
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
DETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy.
The customer will deploy NurseMagic™ AI documentation across its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours1 per caregiver per week.
This win represents a step-function increase in scale, substantially expanding NurseMagic™’s enterprise census footprint and demonstrating the platform’s ability to operate across complex organizations.
Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “This 2,700-census deployment validates the strength of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients — without the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic™ is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding. This achievement reflects the successful transition from an assistive tool to core clinical infrastructure in the
“We executed this deployment with the same financial discipline we have applied across the company over the last several quarters,” said Sarah Berman, Principal Finance and Accounting Officer. “By building NurseMagic™ as an AI-first, configurable platform, we have been able to automate work that historically required significant human support. That approach has contributed to approximately
Madison Bush, Director of Corporate Operations, said “Our sales and marketing flows are delivering approximately 4,200 web visits per day and a steadily growing volume of inbound interest from providers who are actively seeking AI-first alternatives or improvements to legacy systems. We are already engaged in advanced discussions with additional organizations representing several thousand more patients in aggregate census — over
With customers ranging from smaller providers to enterprise organizations with thousands of patient censuses, NurseMagic™ is now proven across the full spectrum of non-acute care operations.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statement
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
Sources
- https://www.aacn.org/blog/nursing-documentation-burden-a-critical-problem-to-solve
- https://www.grandviewresearch.com/industry-analysis/us-skilled-nursing-facility-market
- https://www.ibisworld.com/united-states/industry/home-care-providers/1579/
- https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report
- https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report
- https://www.grandviewresearch.com/industry-analysis/us-hospice-market
- https://www.aaltci.org/news/long-term-care-insurance-news/out-of-pocket-expenditures-for-nursing-home-care-expenditures-to-grow
